Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-05 Sale |
2025-03-17 4:26 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,766 | $88.8 | $512,021 | 146,630 (Direct) |
View |
| 2025-03-12 Sale |
2025-03-14 4:36 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
7,500 | $87.8 | $658,500 | 249,896 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 7:53 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,161 | $109.53 | $1,660,511 | 257,396 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 6:04 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $102.28 | $511,400 | 272,557 (Direct) |
View |
| 2024-12-19 Sale |
2024-12-20 4:15 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,000 | $89.77 | $1,346,615 | 277,557 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-12 4:15 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $102 | $510,000 | 292,557 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 4:53 pm |
Spyre Therapeutics Inc. | SYRE | Albers Jeffrey W. Director |
6,700 | $36.76 | $246,313 | 27,360 (Indirect) |
View |
| 2024-10-25 Sale |
2024-10-28 4:41 pm |
Spyre Therapeutics Inc. | SYRE | Albers Jeffrey W. Director |
300 | $36.43 | $10,929 | 34,060 (Indirect) |
View |
| 2024-09-09 Sale |
2024-09-11 4:06 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
19,702 | $85.57 | $1,685,891 | 297,557 (Direct) |
View |
| 2024-08-26 Sale |
2024-08-26 6:31 pm |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $49.1 | $245,509 | 11,349 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-26 9:11 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
11,033 | $90.69 | $1,000,583 | 165,017 (Direct) |
View |
| 2024-03-20 Sale |
2024-03-22 5:50 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,073 | $87.28 | $2,188,265 | 176,050 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 6:46 pm |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $39.05 | $195,258 | 37,083 (Direct) |
View |
| 2024-01-25 Sale |
2024-01-29 6:13 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $81.91 | $2,047,800 | 193,619 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-23 7:37 pm |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
10,000 | $30.05 | $300,470 | 21,349 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-13 3:56 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $79.07 | $395,350 | 326,050 (Direct) |
View |
| 2023-11-30 Sale |
2023-12-04 4:02 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $70.55 | $352,750 | 331,050 (Direct) |
View |
| 2023-11-24 Sale |
2023-11-28 4:05 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,000 | $67.51 | $1,012,690 | 206,123 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 5:07 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $60.2 | $601,980 | 663,654 (Direct) |
View |
| 2023-09-27 Sale |
2023-09-29 2:36 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $49.76 | $1,244,030 | 273,094 (Direct) |
View |
| 2023-08-24 Sale |
2023-08-28 6:23 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $49.81 | $1,245,150 | 326,196 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 9:28 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
9,793 | $45.67 | $447,273 | 173,450 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-07 8:52 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
20,000 | $50.09 | $1,001,800 | 298,316 (Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 5:53 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $70.45 | $704,534 | 251,653 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 7:55 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
20,000 | $68.41 | $1,368,253 | 328,316 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-10 7:31 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $70.07 | $700,700 | 298,316 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-18 4:05 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
20,000 | $55.89 | $1,117,815 | 351,146 (Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 4:05 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
5,000 | $70.11 | $350,550 | 243,243 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-08 4:06 pm |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
32,705 | $57.9 | $1,893,712 | 376,146 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-12 Exercise |
2025-03-14 4:36 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
7,500 | $0 | 249,896 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-14 4:36 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
7,500 | $36.05 | 249,896 (Direct) |
View |
| 2025-01-21 Exercise |
2025-01-23 7:53 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $0 | 257,396 (Direct) |
View |
| 2025-01-21 Exercise |
2025-01-23 7:53 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $36.05 | 257,396 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 6:04 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $0 | 272,557 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 6:04 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $36.05 | 272,557 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 4:15 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,000 | $36.05 | 277,557 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-12 4:15 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $0 | 292,557 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-12 4:15 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $36.05 | 292,557 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-11 4:06 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $0 | 297,557 (Direct) |
View |
| 2024-09-09 Exercise |
2024-09-11 4:06 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $36.05 | 297,557 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-26 6:31 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $10.34 | 11,349 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-26 6:31 pm |
N/A 2030-07-28 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $0 | 11,349 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 5:00 pm |
N/A 2034-06-17 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 5:41 pm |
N/A 2034-06-12 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
6,812 | $0 | 171,829 (Direct) |
View |
| 2024-05-14 Option Award |
2024-05-16 4:10 pm |
N/A 2034-05-14 |
Spyre Therapeutics Inc. | SYRE | Albers Jeffrey W. Director |
11,323 | $0 | 11,323 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 5:50 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,073 | $1.87 | 176,050 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 5:50 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,073 | $0 | 176,050 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 5:50 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $15.01 | 176,050 (Direct) |
View |
| 2024-02-20 Exercise |
2024-02-21 6:46 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $10.34 | 37,083 (Direct) |
View |
| 2024-02-20 Exercise |
2024-02-21 6:46 pm |
N/A 2030-07-28 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
5,000 | $0 | 37,083 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 6:13 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,000 | $1.87 | 193,619 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 6:13 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $0 | 193,619 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-29 6:13 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $15.01 | 193,619 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-23 7:37 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
10,000 | $10.34 | 21,349 (Direct) |
View |
| 2024-01-23 Exercise |
2024-01-23 7:37 pm |
N/A 2030-07-28 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
10,000 | $0 | 21,349 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 3:56 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $0 | 326,050 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-13 3:56 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $36.05 | 326,050 (Direct) |
View |
| 2023-11-22 Option Award(A) |
2023-12-08 4:07 pm |
N/A 2033-11-22 |
Spyre Therapeutics Inc. | SYRE | Albers Jeffrey W. Director |
50,000 | $0 | 84,360 (Direct) |
View |
| 2023-11-24 Conversion(A) |
2023-12-08 4:07 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Albers Jeffrey W. Director |
35,219 | $0 | 84,360 (Indirect) |
View |
Ownership(A) |
2023-12-08 4:03 pm |
N/A N/A |
Spyre Therapeutics Inc. | SYRE | Albers Jeffrey W. Director |
0 | $0 | 34,360 (Indirect) |
View |
| 2023-11-30 Exercise |
2023-12-04 4:02 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $0 | 331,050 (Direct) |
View |
| 2023-11-30 Exercise |
2023-12-04 4:02 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
5,000 | $36.05 | 331,050 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,000 | $1.87 | 206,123 (Direct) |
View |
| 2023-11-24 Exercise |
2023-11-28 4:05 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
15,000 | $0 | 206,123 (Direct) |
View |
| 2023-11-22 Option Award |
2023-11-27 4:36 pm |
N/A 2033-11-22 |
Spyre Therapeutics Inc. | AGLE | Albers Jeffrey W. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-11-01 Exercise |
2023-11-03 5:07 pm |
N/A 2027-02-16 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $0 | 663,654 (Direct) |
View |
| 2023-11-01 Exercise |
2023-11-03 5:07 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $36.05 | 663,654 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 2:36 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $1.87 | 273,094 (Direct) |
View |
| 2023-09-27 Exercise |
2023-09-29 2:36 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $0 | 273,094 (Direct) |
View |
| 2023-08-24 Exercise |
2023-08-28 6:23 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $1.87 | 326,196 (Direct) |
View |
| 2023-08-24 Exercise |
2023-08-28 6:23 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
25,000 | $0 | 326,196 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 7:07 pm |
N/A 2033-06-21 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
7,900 | $0 | 181,350 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:15 pm |
N/A 2033-06-14 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 8:52 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $1.87 | 298,316 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 8:52 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
20,000 | $0 | 298,316 (Direct) |
View |
| 2022-12-05 Exercise |
2022-12-07 8:52 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $15.01 | 298,316 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 5:53 pm |
N/A 2026-02-03 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $0 | 251,653 (Direct) |
View |
| 2022-08-19 Exercise |
2022-08-23 5:53 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $15.01 | 251,653 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 7:55 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $1.87 | 328,316 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 7:55 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
20,000 | $0 | 328,316 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 7:55 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $15.01 | 328,316 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 7:31 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
7,170 | $8.8 | 298,316 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 7:31 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
2,830 | $1.87 | 298,316 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 7:31 pm |
N/A 2025-02-10 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $0 | 298,316 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 6:34 pm |
N/A 2032-06-27 |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:05 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $1.87 | 351,146 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:05 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
20,000 | $0 | 351,146 (Direct) |
View |
| 2022-05-16 Exercise |
2022-05-18 4:05 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. Director |
10,000 | $15.01 | 351,146 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:05 pm |
N/A 2026-02-03 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
5,000 | $0 | 243,243 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:05 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
5,000 | $15.01 | 243,243 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:06 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
7,500 | $1.87 | 376,146 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:06 pm |
N/A 2024-07-30 |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
20,000 | $0 | 376,146 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:06 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Albers Jeffrey W. CEO AND PRESIDENT |
12,500 | $15.01 | 376,146 (Direct) |
View |